Scotiabank lowered the firm’s price target on Methanex (MEOH) to $48 from $50 and keeps an Outperform rating on the shares. Following Q3 results, Methanex remains a top pick for Scotiabank under its Chemicals coverage, the analyst tells investors. The firm lowered its price target on the stock due to low Q3 EBITDA moving B/S leverage “in the wrong direction.”
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MEOH:
- Methanex Earnings Call: Integration Success Amid Market Challenges
- Positive Outlook for Methanex: Buy Rating Backed by Strong Operations and Strategic Initiatives
- Methanex upgraded to Overweight from Neutral at JPMorgan
- Methanex Reports Q3 2025 Results Amid Production Boost
- Methanex Reports Q3 2025 Results with Increased Production and Strategic Financial Moves
